Please login to the form below

Not currently logged in
Email:
Password:

Par elects new chairman

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

US generic drug manufacturer Par Pharmaceutical has elected president and CEO Patrick G LePore as chairman of the board of directors.

LePore, who joined Par's board in May 2006, has been president and CEO since September 2006.

LePore replaces John D Abernathy as chairman. Abernathy will remain a board member.

Joseph E Smith, a member of the board since 2004, has been named lead director. Prior to his retirement in 1997, he held leadership positions with Warner-Lambert.

On 9 August, Par's shares fell USD 0.73, or 3.5 per cent, to USD 20.03 in pm trading. Shares have traded between USD 15.50 and USD 30.68 over the past year.

10th August 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics